Condition

Leg Ulcer

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 19 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials19

Recruiting5

Common interventions25

Lead sponsors shown15

Clinical trials

19 shown

Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg UlcersNCT07089602 · 2025-07-15

Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUsNCT06674980 · 2024-12-20

Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers.NCT06826339 · 2024-12-06

Modified Multi-Platform Trial Assessing Multiple CAMPs and SOC vs SOC Alone in the Treatment of DFU and VLUsNCT06560502 · 2024-08-01

A Real-World Registry of Chronic Wounds and UlcersNCT02280733 · 2005-01-01

Performance and Safety of Mepilex® Up in Leg and Foot Ulcers and Skin TearsNCT07782008 · 2026-08-31

NOT_YET_RECRUITING

Time to Heal (Wound, Healing, Dialogue, Nutrition)NCT06255288 · 2024-01-23

Pivotal Study of an Antimicrobial Wound Dressing to Treat Chronic WoundsNCT05619237 · 2022-12-06

Study to Examine Clinical Performance and Safety of Cutimed® Gelling Fiber in Routine Clinical PracticeNCT05148390 · 2022-04-24

Open Label Single Arm Proof of Concept Trial to Evaluate the Efficacy and Safety of Cytori Celution System in Diabetic Leg UlcersNCT05274295 · 2022-02-28

Autologous Transplantation of BM-ECs With Platelet-Rich Plasma Extract for the Treatment of Critical Limb IschemiaNCT02993809 · 2018-03-01

Evaluation Of An Advanced Borderless DressingNCT03146845 · 2017-06-15

Cooling Leg and Foot Ulcer Skin Post Healing to Prevent Ulcer RecurrenceNCT02626156 · 2015-06-01

Safety and Efficacy of Autologous Bone Marrow Stem Cells for Lower Extremity Ischemia TreatingNCT01903044 · 2014-09-01

Proof of Concept (Design Validation) in Patient With Hard to Heal Wounds Such as Pressure Ulcer, Diabetic Foot Ulcer and Leg Ulcer, LeiaNCT01966380 · 2013-09-01

Immune Response of Patients With Chronic, Staphylococcus Aureus-infected WoundsNCT01551667 · 2012-11-01

Olivamine-containing Products in the Management of Patients With Nonhealing Lower Extremity UlcersNCT01657318 · 2012-09-01

Autologous Bone Marrow Stem Cell Transplantation for Critical, Limb-threatening IschemiaNCT00434616 · 2007-04-01

Obtaining and Storing Standard of Care Wound Biopsies for Immediate or Future Wound-Related Scientific StudyNCT00759889 · 2007-03-01

Common interventions

Leading sponsors

Molnlycke Health Care AB 2 BioLab Holdings 1 BSN Medical GmbH 1 C5 Biomedical 1 Centre Hospitalier Universitaire de Nīmes 1 Chester Ho, MD 1 De La Salle University Medical Center 1 Franziskus-Krankenhaus 1 Hvidovre University Hospital 1 Medical University of South Carolina 1 Pontifícia Universidade Católica do Paraná 1 Smith & Nephew, Inc. 1 South China Research Center for Stem Cell and Regenerative Medicine 1 Southwest Regional Wound Care Center 1 Stability Biologics 1

Trial status mix

COMPLETED7

RECRUITING5

UNKNOWN4

TERMINATED2

NOT_YET_RECRUITING1

Phase mix

NA7

PHASE24

PHASE12

PHASE42

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.